
Up to 91% of patients reached EASI-75 and up to 67% reached IGA 0/1 at week 152, with no new safety signals, according to Galderma's EADV 2026 data.
Do you have a specific clinical pearl that you'd like to share with your colleagues? Dermatology Times wants to hear from you!
Do you have a specific clinical pearl that you’d like to share with your colleagues? Dermatology Times wants to hear from you!
We’re creating a series of podcasts to showcase your best tips. We’re in the process of collecting information from dermatologists who are interested in sharing a trick or two to help other derms enhance their clinical practice.
You may have a unique off-label use for a certain drug, or a little-known technique to reduce trauma during filler injections. Whatever your pearl, we want to know about it so that we can share it in a convenient audio format with the rest of our readers!






